FOX CHASE CANCER CENTER
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Organ Preservation in Early Rectal Cancer Patients
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT03548961
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 39
- Registration Number
- NCT03527108
- Locations
- ๐บ๐ธ
NYU Langone, New York, New York, United States
๐บ๐ธFox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Development of Real-time Image-guided Radiotherapy
- Conditions
- First Posted Date
- 2018-05-14
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 159
- Registration Number
- NCT03524248
- Locations
- ๐บ๐ธ
Temple University Hospital, Philadelphia, Pennsylvania, United States
Mychoice: Testing an Interactive mHealth Tool
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2021-01-27
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 257
- Registration Number
- NCT03427177
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
๐บ๐ธThomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
๐บ๐ธTemple University, Philadelphia, Pennsylvania, United States
Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance
- Conditions
- Interventions
- First Posted Date
- 2017-10-17
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT03311958
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Pilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle Aspirate
- Conditions
- Interventions
- First Posted Date
- 2017-10-17
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT03311620
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT03310567
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy
- Conditions
- Interventions
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT03302247
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT03291028
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
VM110 in Detection of Microscopic Tumors: A Phase I Study
- Conditions
- Interventions
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT03286062
- Locations
- ๐บ๐ธ
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States